PRESS RELEASE published on 08/28/2025 at 07:10, 1 year 1 month ago EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth Revenues EBIT EDAG Engineering Group AG Defence Activities Market Restraint
PRESS RELEASE published on 08/28/2025 at 07:02, 1 year 1 month ago Press release: Leonteq expands market presence with leverage products on BX Swiss Leonteq expands market presence with leverage products on BX Swiss, launching over 5,000 products with leading execution quality and strategic growth plans Switzerland Leonteq BX Swiss Market Presence Leverage Products
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago SoftwareOne reports revenue decline and improved margin as expected in H1 2025; Crayon integration on track SoftwareOne Holding AG reports revenue decline and improved margin in H1 2025, including Crayon integration progress. Company outlook focuses on growth and synergy achievements Revenue Decline SoftwareOne Margin Improvement H1 2025 Crayon Integration
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Positive development across all major KPI: STRABAG on track for profitable growth STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth Profitable Growth STRABAG SE EBIT Growth First Half 2025 Results Output Increase
REGULATED PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals Biophytis Sarcopenia Phase 3 EMA Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Exail strengthens its position in the surface drone sector with the first sale of a new long-range DriX drone model Exail Technologies announces the sale of the DriX H-9, expanding its autonomous surface drone solutions for civil and defense markets. The H-9 offers enhanced capabilities for maritime missions Exail Technologies Defense Applications Autonomous Drones DriX H-9 Maritime Missions
PRESS RELEASE published on 08/28/2025 at 06:59, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 06:57, 1 year 1 month ago EQS-Adhoc: PIERER Mobility AG: Results for the first half of 2025 PIERER Mobility AG announces successful completion of restructuring proceedings in H1 2025, with positive results and strategic initiatives for motorcycle and bicycle segments PIERER Mobility AG Results Motorcycle Restructuring Proceedings Bicycle
PRESS RELEASE published on 08/28/2025 at 06:50, 1 year 1 month ago Daldrup & Söhne AG increases EBIT margin and specifies EBIT forecast Daldrup & Söhne AG increases EBIT margin to 12.6% and revises 2025 EBIT forecast. Order backlog reaches EUR 140 million. Detailed 2025 outlook provided Financial Performance EBIT Margin Order Backlog Forecast Daldrup & Söhne
Published on 10/23/2026 at 21:55, 1 hour 12 minutes ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 7 hours 7 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 9 hours 44 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 10 hours 7 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 02:20, 20 hours 47 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 18:55, 4 hours 12 minutes ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 5 hours 7 minutes ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 17:55, 5 hours 12 minutes ago Hears Everything, Uploads Nothing: VoxNexus Launches Android's First Low-Power On-Device Always-On Voice Artificial Intelligence (AI)
Published on 10/23/2026 at 17:45, 5 hours 22 minutes ago Charwood Energy: Change to the Financial Calendar
Published on 10/23/2026 at 17:35, 5 hours 32 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 10/23/2026 at 20:33, 2 hours 33 minutes ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 5 hours 22 minutes ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 1 day 5 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 1 day 5 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics